Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vulvovaginal Atrophy Questionnaire (VVAQ): Psychometric Validation of a Novel Patient Reported Outcome Measure (PROM)

NCT04746456 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT04746456
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04746456 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vulvovaginal Atrophy Questionnaire (VVAQ): Psychometric Validation of a Novel Patient Reported Outcome Measure (PROM)
Lead sponsor
Massachusetts General Hospital
Phase
Observational
Overall status
Completed
Start date
September 1, 2022
Completion date
May 1, 2024
Enrollment
210 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

genitourinary syndrome of menopause, menopause, vulvovaginal atrophy